Lack of MHC class I surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinomas

British Journal of Cancer

Volumn 81, Issue 5, 1999, Pages 881-889

  Cruz, I ^a   Meijer, C J L M ^a   Walboomers, J M M ^a   Snijders, P J F ^a   Van Der Waal, I ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

2 microglobulin; CTLs; Granzyme B; MHC class I; NK cells; Oral carcinoma

Indexed keywords

ANTIBODY; BETA 2 MICROGLOBULIN; CD57 ANTIGEN; CD8 ANTIGEN; GRANZYME B; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PERFORIN;

ADULT; AGED; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUTH CARCINOMA; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; GRANZYMES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032699791     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690780     Document Type: Article

References (31)

1. Bennett MW, O'Connell J, O'Sullivan GC, Brady C, Roche D, Collins JK and Shanahan F (1998) The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. J Immunol 160: 5669-5675
2. Berke C (1997) Killing mechanisms of cytotoxic lymphocytes. Curr Opin Hematol 4: 32-40
3. Bicknell DC, Rowan A and Bodmer WF (1994) β2-microglobulin mutations: a study of established colorectal cell lines and fresh tumours. Proc Natl Acad Sci USA 91: 4751-4755
4. Bobrow MN, Harris TD, Shaughnessy KJ and Litt GJ (1989) Catalysed reporter deposition, a novel method of signal amplification. J Immunol Methods 125: 279-285
5. Bontkes HJ, De Gruijl TD, Walboomers JMM, Van den Muysenberg AJC, Gunther AW, Scheper RJ, Meijer CJLM and Kummer JA (1997) Assessment of cytotoxic. T lymphocyte phenotype using the specific markers granzyme B and TIA-I in cervical neoplastic lesions. Br J Cancer 76: 1353-1360
6. Brinkhuis M, Mogensen O, Bichel P and Baak JPA (1995) The significance of differences in prognostic value of quantitative pathologic features in FIGO stage III and IV serons adenocarcinoma of the ovary between a group of Danish patients and other groups. Int J Gynecol Cancer 5: 355-360
7. Chambers CA and Allison JP (1997) Co-stimulation in T cell responses. Curr Opin Immunol 9: 396-404
8. Chapman TL and Bjorkman PJ (1998) Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog. J Virol 72: 460-466
9. Cruz IB, Snijders PJF, Meijer CJ, Braakhuis BJ, Snow GB, Walboomers JM and Van der Waal I (1998) p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol 184: 360-368
10. Ding L, Linsley PS, Buang LY, Germain RN and Shevach EM (1993) IL-10 inhibits macrophage co-stimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 151: 1224-1234
11. D'Urso CM, Wang Z, Cao Y, Tatake R, Zeff RA and Ferrone S (1991) Lack of HLA class 1 antigen expression by cultured melanoma cells FO-1 due to a defect in β2-m gene expression. J Clin Invest 87: 284-292
12. Froelich CJ, Dixit VM and Yang X (1998) Lymphocyte granule-mediated apoptosis: matters of viral mimicry and deadly proteases. Immunol Today 19: 30-37
13. Gomez J, Gozalez A, Martinez-A C and Rebollo A (1998) IL-2-induced cellular events. Crit Rev Immunol 18: 185-220
14. Kagi D, Ledermann B, Burki K, Zinkernagel RM and Hengartner H (1996) Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo, Annu Rev Immunol 14: 207-232
15. Klein E, Klein G, Nadkarni JS, Nadkarni JJ, Wigzell H and Clifford P (1967) Surface IgM specificity on cells derived from a Burkitt's lymphoma. Lancet ii: 1068-1070
16. Kos FJ and Engleman EG (1996) Immune regulation: a critical link between NK cells and CTLs. Immunol Today 17: 174-176
17. Kummer JA, Kamp AM, Van Katwijn M, Brakenhof JP, Radosevic K, Van Leeuwen AM, Borst J, Verwey CL and Haek CE (1993) Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B showing cross reactions with the natural proteins. J Immunol Methods 163: 77-83
18. Kummer JA, Kamp AM, Tadema TM, Vos W, Meijer CJLM and Hack CE (1995) Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral blood. Clin Exp Immunol 100: 164-172
19. Lanier LL and Phillips JH (1996) Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today 17: 86-91
20. Lichtenstein A, Zighelboim J, Dorey F, Brossman S and Fahey JL (1980) Comparison of immune derangements in patients with different malignancies. Cancer 45: 2090-2095
21. Mingari MC, Moretta A and Moretta L (1998) Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. Immunoly Today 19: 153-157
22. Parham P (1995) Antigen presentation by class I major histocompatibility complex molecules: a context for thinking about HLA-G, Am J Reprod Immunol 34: 10-19
23. Prime SS, Pitigala-Arachehi A, Crane IJ, Rosser TJ and Scully C (1987) The expression of cell surface MHC class I heavy and light chain molecules in pre-malignant and malignant lesions of the oral mucosa. Histopathology 11: 81-91
24. Reichert TE, Day R, Wagner EM and Whiteside TL (1998) Absent or low expression of the zeta chain in T cells at the tumour site correlates with poor survival in patients with oral carcinoma. Cancer Res 58: 5344-5347
25. Rosa F, Berissi H, Weissenbach J, Maroteaux L, Fellous M and Revel M (1983) The β2-microglobulin RNA in human Daudi cell has a mutated initiation codon but is still inducible by interferon. EMBO J 2: 239-243
26. Stam NJ, Spits H and Ploegh HL (1986) Monoclonal antibodies raised against denaturated HLA-B locus heavy chains permit biochemical characterization of certain HLA C locus products. J Immunol 137: 2299-2306
27. Stam NJ, Vroom ThM, Peters PJ, Pastoors EB and Ploegh HL (1990) HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in Western blots, in formalin-fixed, paraffin embedded tissue sections and in cryo immuno-electron microscopy. Int Immunol 2: 113-125
28. Van den Broek MF, Kagi D, Zinkernagel RM and Hengartner H (1995) Perform dependence of natural killer cell-mediated tumour control in vivo. Eur J Immunol 25: 3514-3516
29. Wanebo HJ, Jun MY, Strong EW and Oettgen H (1975) T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg 130: 445-451
30. Whiteside TL, Chikamatsu K, Nagashima S and Okada K (1996) Anti-tumor effects of cytotoxic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancer. Anticancer Res 16: 2357-2364
31. Yokoyama WM (1995) Natural killer cell receptors. Curr Opin Immunol 7: 110-120